US20050159640A1
Expired / Lapsed
US
⏱️ 0.0 years remaining
Cerebral perfusion augmentation
Assignee: Zoll Circulation Inc
•
Filing: 2005-01-24
•
Granted: —
•
Expires: 2025-01-24
Abstract
Abstract Methods are provided for partial aortic obstruction for cerebral perfusion augmentation in patients suffering from global or focal cerebral ischemia. Alternatively, the methods can be used to partially obstruct aortic blood flow to condition the spinal cord to secrete neuroprotective agents prior to abdominal aortic aneurysm repair. Partial obstruction of a vessel can be accomplished by a device comprising an elongate catheter and a distally mounted expandable member. The expandable member may comprise one or two balloons. Other medical devices, such as an angioplasty, stent, or atherectomy catheter, can be inserted distal the expandable member to provide therapeutic intervention.
Inventors
- 👤 Denise Barbut
- 👤 Peter Keith
- 👤 Steven Berhow
- 👤 Jon St. Germain
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 00:54
CPC Classifications
A; A61; A61B; A61B17/00; A61B17/12; A61B17/12022; A61B17/12027; A61B17/1204; A61B17/12045; A61B17/12036; A61B17/12099; A61B17/12109; A61B17/12131; A61B17/12136; A61B17/1214; A61B17/12145; A61B17/12181; A61B17/1219; A61B5/00; A61B5/02; A61B5/021; A61B5/0215; A61B5/40; A61B5/4076; A61B6/00; A61B6/48; A61B6/481; A61F; A61F7/00; A61F7/12; A61M; A61M25/00; A61M25/0021; A61M25/0023; A61M25/0026; A61M25/003; A61M25/0067; A61M25/0068; A61M25/008; A61M25/0082; A61M25/01; A61M25/0105; A61M25/0133; A61M25/0147; A61M25/10; A61M25/1011; A61B17/22; A61B2017/22051; A61B2017/22054; A61B90/00; A61B90/39; A61B2090/3966; A61F2/00; A61F2/02; A61F2/04; A61F2/06; A61F2002/068; A61F2007/126; A61M2025/0001; A61M2025/0002; A61M2025/0034; A61M2025/0073; A61M2025/0081; A61M2025/1043; A61M2025/1052; A61M2210/00; A61M2210/12; A61M2210/127; A61M2230/00; A61M2230/005; A61M2230/30; A61M25/0032; A61M25/0069; A61M25/0074; A61M25/06; A61M25/0662
Claims Analysis
Total Claims: 6
Claim 1
Independent Claim
92 words
1 . A method for increasing cerebral blood flow, comprising the steps of: advancing a catheter into the descending aorta, the catheter having a proximal region, a distal region, and an expandable member mounted on the distal region; locating the expandable member in the descending aorta; expanding the expandable member to partially obstruct blood flow in the aorta during systole and diastole; measuring a physiologic parameter; and adjusting the expansion of the expandable member based on the measured physiologic parameter, wherein cerebral blood flow is increased without substantially increasing cerebral blood pressure.
Claim 2
Dependent Claim
92 words
1 . A method for increasing cerebral blood flow, comprising the steps of: advancing a catheter into the descending aorta, the catheter having a proximal region, a distal region, and an expandable member mounted on the distal region; locating the expandable member in the descending aorta; expanding the expandable member to partially obstruct blood flow in the aorta during systole and diastole; measuring a physiologic parameter; and adjusting the expansion of the expandable member based on the measured physiologic parameter, wherein cerebral blood flow is increased without substantially increasing cerebral blood pressure.
Claim 3
Dependent Claim
15 words
2 . The method of claim 1 , wherein the physiologic parameter is blood pressure.
Claim 4
Dependent Claim
16 words
3 . The method of claim 1 , wherein the physiologic parameter is cerebral blood flow.
Claim 5
Dependent Claim
15 words
4 . The method of claim 1 , wherein the expandable member is a balloon.
Claim 6
Dependent Claim
17 words
5 . The method of claim 1 , wherein blood flow is increased by at least 20%.
References Cited (Backward Citations)
US3692018A
Cited
US3634924A
Cited
US3720200A
Cited
US4368739A
Cited
US4600015A
Cited
US4531936A
Cited
US4883459A
Cited
US4798588A
Cited
US4601706A
Cited
US4712566A
Cited
US4697574A
Cited
US4744863A
Cited
US4996082A
Cited
US4853669A
Cited
US4733669A
Cited
US4701160A
Cited
US4941473A
Cited
US4723549A
Cited
US4777951A
Cited
US5002532A
Cited
US5085223A
Cited
US5116305A
Cited
USRE35648E
Cited
US5820593A
Cited
US5221258A
Cited
US5290247A
Cited
US5711754A
Cited
US5814016A
Cited
US5702368A
Cited
US5195942A
Cited
US5334142A
Cited
US5449342A
Cited
US5216032A
Cited
US5330498A
Cited
US5392117A
Cited
US5202939A
Cited
US5824034A
Cited
US5599329A
Cited
US5330451A
Cited
US5855210A
Cited
US5531776A
Cited
US5458574A
Cited
US5437633A
Cited
US5486192A
Cited
US5716386A
Cited
US5662571A
Cited
US5678570A
Cited
US5827237A
Cited
US6010522A
Cited
US6296654B1
Cited
US5891012A
Cited
US6165199A
Cited
US6161547A
Cited
US6767345B2
Cited
US6146370A
Cited
US6190304B1
Cited
US6468200B1
Cited
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.